Pórszász, RóbertKim, Saebom2017-08-232017-08-232017-05-16http://hdl.handle.net/2437/243133AML is a clonal disorder of myeloid progenitors with the distinct features of clinical and biological heterogeneity. Chemotherapy has been a foundational management of AML in the past 40 years. It mainly consists of 2 phases : induction chemotherapy and consolidation therapy. Most tumor cells are rapidly eliminated and the patients put into a remission state in the remission induction phase. Consolidation is the intensive management after remission to get rid of the residual leukemic cells.31enAcute myeloid leukemiaDEENK Témalista::Orvostudomány::Gyógyszerésztudomány